Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Thomas, William Carman (1980)
Hepatitis B VaccineThe Lancet, 316
H. Gidding, Margaret Warlow, C. MacIntyre, J. Backhouse, G. Gilbert, H. Quinn, P. McIntyre (2007)
The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia.Vaccine, 25 51
(2013)
High risk hepatitis B immunisation program
Banatvala J Van Damme P Van Hattum J
Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity.
N. Gamagedara, Ajith Weerakoon, H. Zou, G. Fehler, Marcus Chen, T. Read, C. Bradshaw, C. Fairley (2013)
Cross-sectional study of hepatitis B immunity in MSM between 2002 and 2012Sexually Transmitted Infections, 90
A. Body, J. Hoy, A. Cheng, M. Giles (2014)
Incident hepatitis B infection subsequent to the diagnosis of HIV infection in a Melbourne cohort: missed opportunities for prevention.Sexual health, 11 1
Tzu-Wei Wu, H. Lin, Li‐Yu Wang (2013)
Chronic hepatitis B infection in adolescents who received primary infantile vaccinationHepatology, 57
Mast EE Weinbaum CM Fiore AE Alter MJ Bell BP Finelli L et al
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization
J. MacLachlan, N. Allard, V. Towell, B. Cowie (2013)
The burden of chronic hepatitis B virus infection in Australia, 2011Australian and New Zealand Journal of Public Health, 37
C. Rock, E. Barra, C. Sadlier, S. Kelly, C. Dowling, C. McNally, C. Bergin (2013)
Impact of a new vaccine clinic on hepatitis B vaccine completion and immunological response rates in an HIV-positive cohort.Journal of infection and public health, 6 3
Qian Wu, G. Zhuang, Xue-liang Wang, Li-rong Wang, Na Li, Min Zhang (2011)
Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.Vaccine, 29 12
Gm Clifford, M. Rickenbach, S. Franceschi, Swiss Hiv, C. Study (2009)
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinomaInfectious Agents and Cancer, 4
B. Cowie, T. Karapanagiotidis, A. Enríquez, H. Kelly (2010)
Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005Australian and New Zealand Journal of Public Health, 34
H. Gatanaga, Tsunefusa Hayashida, J. Tanuma, S. Oka (2013)
Prophylactic effect of antiretroviral therapy on hepatitis B virus infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 56 12
O. Launay, D. Vliet, A. Rosenberg, M. Michel, L. Piroth, D. Rey, N. Verdière, L. Slama, Karine Martin, O. Lortholary, F. Carrat (2011)
Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.JAMA, 305 14
D. Potsch, L. Camacho, S. Tuboi, L. Villar, J. Miguel, C. Ginuíno, Elisângela Silva, R.M.M. Mendonça, R. Moreira, P. Barroso (2012)
Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.Vaccine, 30 41
Szmuness W Stevens CE Harley EJ Zang EA Oleszko WR William DC et al
Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.
V. Lopes, R. Hassing, T. Vries-Sluijs, A. Barzouhi, B. Hansen, M. Schutten, R. Man, M. Ende (2013)
Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.Vaccine, 31 7
B. McMahon, C. Dentinger, D. Bruden, C. Zanis, H. Peters, D. Hurlburt, L. Bulkow, A. Fiore, B. Bell, T. Hennessy (2009)
Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose.The Journal of infectious diseases, 200 9
L. Topp, C. Day, H. Wand, Rachel Deacon, I. Beek, P. Haber, M. Shanahan, C. Rodgers, L. Maher (2013)
A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia.Preventive medicine, 57 4
V. Macdonald, G. Dore, J. Amin, I. Beek (2007)
Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre.Sexual health, 4 1
P. Tiollais, Marie-Annick Buendia (1991)
Hepatitis B virus.Scientific American, 264 4
A. Bradford (2000)
The Australian Immunisation HandbookAustralian Infection Control, 5
E. Wheeler, B. Cowie (2011)
Be aware--hepatitis B as an STI.Australian nursing journal, 19 6
B. McMahon, W. Alward, D. Hall, W. Heyward, T. Bender, D. Francis, J. Maynard (1985)
Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state.The Journal of infectious diseases, 151 4
(2000)
Are booster immunisations needed for lifelong hepatitis B immunity?The Lancet, 355
CSIRO PUBLISHING Sexual Health, 2014, 11,1–4 Editorial http://dx.doi.org/10.1071/SH13166 Hepatitis B in men who have sex with men and HIV-infected individuals: missed opportunities and future challenges A,B,D A,B,C Nicole Allard and Benjamin Cowie Department of Medicine, Royal Melbourne Hospital, Royal Parade, Parkville, Vic. 3050, Australia. Victorian Infectious Diseases Reference Laboratory, 10 Wreckyn Street, North Melbourne, Vic. 3051, Australia. Victorian Infectious Diseases Service, The Royal Melbourne Hospital, Grattan Street, Parkville, Vic. 3050, Australia. Corresponding author. Email: Nicole.Allard@mh.org.au Received 14 October 2013, accepted 27 October 2013, published online 26 March 2014 Hepatitis B transmission in priority populations continues to of HIV are often also endemic for CHB, making coinfection occur in Australia despite the availability of a safe, effective with HBV more common in HIV-infected individuals born in 1,2 10 vaccine for over 30 years. In this edition of Sexual Health, these countries who now reside in Australia. Body et al. report an incidence of 1.8 hepatitis B virus (HBV) HIV infection is associated with both an increased risk of infections per 1000 person years in the Victorian HIV database developing CHB if exposed to HBV and an increased risk of (VHIVSD), a cohort of HIV-infected individuals receiving complications, including cirrhosis and
Sexual Health – CSIRO Publishing
Published: Mar 26, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.